PubRank

Vincent Pichette

Author PubWeight™ 41.26‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Supramaximal dose of candesartan in proteinuric renal disease. J Am Soc Nephrol 2009 2.12
2 Rationale for heating oxaliplatin for the intraperitoneal treatment of peritoneal carcinomatosis: a study of the effect of heat on intraperitoneal oxaliplatin using a murine model. Ann Surg 2011 2.09
3 Canadian randomized trial of hemoglobin maintenance to prevent or delay left ventricular mass growth in patients with CKD. Am J Kidney Dis 2005 1.92
4 Cinacalcet hydrochloride is an effective treatment for secondary hyperparathyroidism in patients with CKD not receiving dialysis. Am J Kidney Dis 2005 1.69
5 Down-regulation of hepatic cytochrome p450 in chronic renal failure: role of uremic mediators. Br J Pharmacol 2002 1.14
6 ESRD impairs nonrenal clearance of fexofenadine but not midazolam. J Am Soc Nephrol 2009 1.13
7 Palmitoylation controls recycling in lysosomal sorting and trafficking. Traffic 2008 1.12
8 Effects of chronic renal failure on liver drug transporters. Drug Metab Dispos 2007 1.10
9 Effects of serum from patients with chronic renal failure on rat hepatic cytochrome P450. Br J Pharmacol 2005 1.05
10 Down-regulation of intestinal drug transporters in chronic renal failure in rats. J Pharmacol Exp Ther 2006 1.03
11 Characterization of chronic constriction of the saphenous nerve, a model of neuropathic pain in mice showing rapid molecular and electrophysiological changes. J Neurosci Res 2006 1.00
12 Transplantation of mesenchymal stem cells promotes tissue regeneration in a glaucoma model through laser-induced paracrine factor secretion and progenitor cell recruitment. Stem Cells 2013 1.00
13 Downregulation of intestinal cytochrome p450 in chronic renal failure. J Am Soc Nephrol 2002 1.00
14 Successful treatment of encapsulating peritoneal sclerosis with immunosuppressive therapy. Am J Kidney Dis 2008 1.00
15 Role of parathyroid hormone in the downregulation of liver cytochrome P450 in chronic renal failure. J Am Soc Nephrol 2006 0.98
16 Reduced hepatic synthesis of calcidiol in uremia. J Am Soc Nephrol 2010 0.95
17 Effects of chronic renal failure on kidney drug transporters and cytochrome P450 in rats. Drug Metab Dispos 2011 0.94
18 Effect of hemodialysis on hepatic cytochrome P450 functional expression. J Pharmacol Sci 2008 0.92
19 Atheroembolic renal failure requiring dialysis: potential for renal recovery? A review of 43 cases. Nephron Clin Pract 2003 0.91
20 Current understanding of drug disposition in kidney disease. J Clin Pharmacol 2012 0.90
21 Effect of cinacalcet availability and formulary listing on parathyroidectomy rate trends. BMC Nephrol 2013 0.88
22 Darbepoetin alfa effectively treats anemia in patients with chronic kidney disease with de novo every-other-week administration. Am J Nephrol 2004 0.87
23 Clinical value of inflammatory urinary biomarkers in overt diabetic nephropathy: a prospective study. Diabetes Res Clin Pract 2013 0.86
24 Hypoxia-induced down-regulation of CYP1A1/1A2 and up-regulation of CYP3A6 involves serum mediators. Br J Pharmacol 2002 0.85
25 Interleukin-1beta, interleukin-6, tumour necrosis factor-alpha and interferon-gamma released by a viral infection and an aseptic inflammation reduce CYP1A1, 1A2 and 3A6 expression in rabbit hepatocytes. Eur J Pharmacol 2003 0.84
26 Magnitude of discordance between registry data and death certificate when evaluating leading causes of death in dialysis patients. BMC Med Res Methodol 2013 0.84
27 Downregulation of hepatic acetylation of drugs in chronic renal failure. J Am Soc Nephrol 2008 0.83
28 Acute Kidney Injury and Renal Recovery with the Use of Aminoglycosides: A Large Retrospective Study. Nephron 2015 0.81
29 Organic anion transporting polypeptide 1B1 (OATP1B1) and OATP1B3: genetic variability and haplotype analysis in white Canadians. Drug Metab Pharmacokinet 2010 0.80
30 Urinary monocyte chemotactic protein 1: marker of renal function decline in diabetic and nondiabetic proteinuric renal disease. J Nephrol 2010 0.79
31 A case of an aortic dissection in a young adult: a refresher of the literature of this "great masquerader". Int J Gen Med 2011 0.78
32 Bicarbonates for the prevention of postoperative renal failure in endovascular aortic aneurysm repair: a randomized pilot trial. Anesthesiol Res Pract 2013 0.78
33 Effects of chronic renal failure on brain drug transporters in rats. Drug Metab Dispos 2011 0.77
34 Complement dysregulation in haemolytic uraemic syndrome. Lancet 2003 0.77
35 Down-regulation of liver drug-metabolizing enzymes in a murine model of chronic renal failure. Drug Metab Dispos 2009 0.76
36 Comparison of oral and intravenous alfacalcidol in chronic hemodialysis patients. BMC Nephrol 2014 0.76
37 Comparison of the prevalence of calcidiol insufficiency in predialysis and osteoporotic populations. Int Urol Nephrol 2008 0.76
38 Restoration of renal function by a novel prostaglandin EP4 receptor-derived peptide in models of acute renal failure. Am J Physiol Regul Integr Comp Physiol 2012 0.76
39 Calcidiol deficiency in CKD patients: the role of reduced liver synthesis. Am J Kidney Dis 2012 0.75
40 Effect of parathyroidectomy on vitamin D levels. World J Surg 2015 0.75
41 Evidence that the mouse osteocalcin-related gene does not encode nephrocalcin. Nephron Exp Nephrol 2006 0.75
42 Treatment of gram-positive peritonitis in peritoneal dialysis patients: cefazolin or vancomycin? Perit Dial Int 2004 0.75
43 The effect of lanthanum carbonate on metabolic acidosis in patients with chronic kidney disease stage IV, V and V-D. Int Urol Nephrol 2015 0.75
44 Hemodialysis effects on phenytoin pharmacokinetics. Eur J Clin Pharmacol 2014 0.75
45 The role of sevelamer carbonate in increasing serum bicarbonate in hyperphosphatemic predialysis patients who have metabolic acidosis. Int J Clin Pharmacol Ther 2013 0.75
46 Influence of SLCO1B3 genetic variations on tacrolimus pharmacokinetics in renal transplant recipients. Drug Metab Pharmacokinet 2012 0.75
47 Efficacy of calcitriol compared to alfacalcidol for the treatment of secondary hyperparathyroidism in peritoneal dialysis patients. Int J Clin Pharmacol Ther 2015 0.75
48 An interprofessional team that includes a nurse practitioner and patients with diabetes and chronic kidney disease. CANNT J 1 0.75
49 Use of a fluorescent substrate for the selective quantification of rat CYP3A in the liver and the intestine. J Pharmacol Toxicol Methods 2006 0.75